US Stock MarketDetailed Quotes

LSB LakeShore Biopharma

Watchlist
  • 3.701
  • +0.091+2.53%
Close Jan 3 16:00 ET
  • 3.520
  • -0.181-4.90%
Post 19:49 ET
70.62MMarket Cap-1.31P/E (TTM)

LakeShore Biopharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2024
(FY)Mar 31, 2023
(FY)Mar 31, 2022
(FY)Mar 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-61.80%-295.23M
-5.14%-182.47M
29.63%-173.55M
-246.61M
Net income from continuing operations
-197.96%-433.46M
-37.24%-145.48M
44.74%-106M
---191.83M
Operating gains losses
-20,715.19%-4.45M
-107.80%-21.36K
1,001.39%273.98K
--24.88K
Depreciation and amortization
14.98%42.19M
17.76%36.69M
11.64%31.15M
--27.91M
Deferred tax
-2,016.94%-21.73M
-77.04%1.13M
-71.71%4.94M
--17.45M
Other non cash items
8.03%4.78M
16.79%4.42M
69.61%3.79M
--2.23M
Change In working capital
50.63%-45.79M
25.77%-92.75M
33.08%-124.94M
---186.68M
-Change in receivables
108.41%13.9M
-139.32%-165.25M
69.15%-69.05M
---223.82M
-Change in inventory
-375.23%-86.26M
79.71%-18.15M
-30.16%-89.46M
---68.73M
-Change in prepaid assets
-158.82%-5.29M
-84.82%8.99M
-59.64%59.23M
--146.77M
-Change in payables and accrued expense
-56.23%40.56M
536.95%92.66M
45.11%-21.21M
---38.63M
-Change in other current liabilities
-11.85%-5.09M
-19.86%-4.55M
-70.83%-3.8M
---2.22M
-Change in other working capital
44.06%-3.61M
-881.77%-6.45M
-1,382.67%-656.67K
---44.29K
Cash from discontinued investing activities
Operating cash flow
-61.80%-295.23M
-5.14%-182.47M
29.63%-173.55M
---246.61M
Investing cash flow
Cash flow from continuing investing activities
22.34%-44.25M
80.94%-56.98M
-186.77%-298.92M
-104.24M
Net PPE purchase and sale
16.02%-44.25M
82.16%-52.69M
-183.30%-295.31M
---104.24M
Net intangibles purchase and sale
--0
-18.63%-4.29M
---3.62M
--0
Cash from discontinued investing activities
Investing cash flow
22.34%-44.25M
80.94%-56.98M
-186.77%-298.92M
---104.24M
Financing cash flow
Cash flow from continuing financing activities
-35.34%205.26M
-12.92%317.45M
-50.69%364.56M
739.26M
Net issuance payments of debt
-178.25%-78.93M
-72.33%100.88M
4,315.43%364.56M
--8.26M
Net common stock issuance
--284.2M
--0
--0
--1.59M
Net preferred stock issuance
----
----
----
--729.41M
Net other financing activities
----
--216.57M
----
----
Cash from discontinued financing activities
Financing cash flow
-35.34%205.26M
-12.92%317.45M
-50.69%364.56M
--739.26M
Net cash flow
Beginning cash position
36.63%370.37M
-30.58%271.07M
18,942.60%390.46M
--2.05M
Current changes in cash
-272.08%-134.22M
172.28%78M
-127.78%-107.91M
--388.41M
Effect of exchange rate changes
-51.18%10.4M
285.60%21.3M
-429,159.95%-11.48M
---2.67K
End cash Position
-33.43%246.55M
36.63%370.37M
-30.58%271.07M
--390.46M
Free cash flow
-41.73%-339.48M
49.31%-239.52M
-34.42%-472.48M
---351.49M
Currency Unit
CNY
CNY
CNY
CNY
Audit Opinions
Unqualified Opinion with Explanatory Notes
Unqualified Opinion
--
--
(FY)Mar 31, 2024(FY)Mar 31, 2023(FY)Mar 31, 2022(FY)Mar 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -61.80%-295.23M-5.14%-182.47M29.63%-173.55M-246.61M
Net income from continuing operations -197.96%-433.46M-37.24%-145.48M44.74%-106M---191.83M
Operating gains losses -20,715.19%-4.45M-107.80%-21.36K1,001.39%273.98K--24.88K
Depreciation and amortization 14.98%42.19M17.76%36.69M11.64%31.15M--27.91M
Deferred tax -2,016.94%-21.73M-77.04%1.13M-71.71%4.94M--17.45M
Other non cash items 8.03%4.78M16.79%4.42M69.61%3.79M--2.23M
Change In working capital 50.63%-45.79M25.77%-92.75M33.08%-124.94M---186.68M
-Change in receivables 108.41%13.9M-139.32%-165.25M69.15%-69.05M---223.82M
-Change in inventory -375.23%-86.26M79.71%-18.15M-30.16%-89.46M---68.73M
-Change in prepaid assets -158.82%-5.29M-84.82%8.99M-59.64%59.23M--146.77M
-Change in payables and accrued expense -56.23%40.56M536.95%92.66M45.11%-21.21M---38.63M
-Change in other current liabilities -11.85%-5.09M-19.86%-4.55M-70.83%-3.8M---2.22M
-Change in other working capital 44.06%-3.61M-881.77%-6.45M-1,382.67%-656.67K---44.29K
Cash from discontinued investing activities
Operating cash flow -61.80%-295.23M-5.14%-182.47M29.63%-173.55M---246.61M
Investing cash flow
Cash flow from continuing investing activities 22.34%-44.25M80.94%-56.98M-186.77%-298.92M-104.24M
Net PPE purchase and sale 16.02%-44.25M82.16%-52.69M-183.30%-295.31M---104.24M
Net intangibles purchase and sale --0-18.63%-4.29M---3.62M--0
Cash from discontinued investing activities
Investing cash flow 22.34%-44.25M80.94%-56.98M-186.77%-298.92M---104.24M
Financing cash flow
Cash flow from continuing financing activities -35.34%205.26M-12.92%317.45M-50.69%364.56M739.26M
Net issuance payments of debt -178.25%-78.93M-72.33%100.88M4,315.43%364.56M--8.26M
Net common stock issuance --284.2M--0--0--1.59M
Net preferred stock issuance --------------729.41M
Net other financing activities ------216.57M--------
Cash from discontinued financing activities
Financing cash flow -35.34%205.26M-12.92%317.45M-50.69%364.56M--739.26M
Net cash flow
Beginning cash position 36.63%370.37M-30.58%271.07M18,942.60%390.46M--2.05M
Current changes in cash -272.08%-134.22M172.28%78M-127.78%-107.91M--388.41M
Effect of exchange rate changes -51.18%10.4M285.60%21.3M-429,159.95%-11.48M---2.67K
End cash Position -33.43%246.55M36.63%370.37M-30.58%271.07M--390.46M
Free cash flow -41.73%-339.48M49.31%-239.52M-34.42%-472.48M---351.49M
Currency Unit CNYCNYCNYCNY
Audit Opinions Unqualified Opinion with Explanatory NotesUnqualified Opinion----
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.